Back to search results

Understanding Patient Experiences in Mantle Cell Lymphoma Clinical Trials

This study is looking into the experiences of people with Mantle Cell Lymphoma (a type of non-Hodgkin lymphoma) who are already taking part in clinical trials for new treatments. It's not testing a new drug itself, but rather observing how many patients decide to join these trials and how many stay in them until the end. The goal is to understand why people join and complete these studies. You can join if you are 18 or older, have a confirmed diagnosis of Mantle Cell Lymphoma, and are not in another treatment trial. The study aims to enroll 500 participants, but its current recruitment status is unclear.

Study design
This is an observational study, meaning researchers will watch and collect information from 500 participants who have Mantle Cell Lymphoma.
What's involved
Not specified in the trial record.
Compensation
Not stated in the trial record.
Follow-up
Researchers will look at how many patients enroll in a study within 3 months and how many stay in a study until completion, measured at 12 months.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT06049472

Patient Perspectives in Mantle Cell Lymphoma Clinical Research

Not Yet Recruiting
Not specifiedAges 18+Observational
Power Life Sciences Inc.
~500 participants
Updated 2023-09-22 on ClinicalTrials.gov

At a glance

Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Number of patients who decide to enroll in a mantle cell lymphoma clinical study
Measured over 3 months
+1 more outcome measured

Conditions

Mantle Cell Lymphoma

Explore related trials

Mantle Cell Lymphoma

NCT06049472

Where you'd take part

This study runs at 1 site. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.

  • Power Life Sciences

    San Francisco, Californiastudy coordinator listed

Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.

Study leadership

  • Michael B Gill · STUDY_DIRECTOR · Power Life Sciences Inc.

Who to contact

Michael B Gill
[email protected]
4159004227
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Want this trial checked against your situation?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Confirmed diagnosis of mantle cell lymphoma
No serious medical or psychiatric illness likely to interfere with participation in this clinical study.
Ability to understand and the willingness to sign a written informed consent document.

Exclusion

Concurrent participation in another therapeutic clinical trial.
Subject has an uncontrolled infection
Has known psychiatric or substance abuse disorders that would interfere with cooperation with the requirements of the trial

What this trial measures

  • Number of patients who decide to enroll in a mantle cell lymphoma clinical study3 months
  • Rate of patients who remain in a mantle cell lymphoma clinical study to trial completion12 months